REFLEXION AT ASTRO 2024 | WASHINGTON, DC
IN-BOOTH PRESENTATIONS
SEPTEMBER 29 – OCTOBER 2 | BOOTH #1313
SUNDAY, SEPTEMBER 29
12:00 PM – Treating Multiple Tumors in a Single Plan on the X1
Mason Hazlett, MS
2:00 PM – Clinical Trials Update and the Expansion of SCINTIX Therapy Indications
Karine Al Feghali, MD
2:00 PM – SCINTIX Therapy Clinical Cases at City of Hope
Tyler Watkins, PhD
4:00 PM – Treating Multiple Tumors in a Single Plan on the X1
Mason Hazlett, MS
MONDAY, SEPTEMBER 30
12:15 PM – SCINTIX Therapy Clinical Cases at Yale New Haven Health
Henry Park, MD
2:00 PM – Clinical Trials Update and the Expansion of SCINTIX Therapy Indications
Dorine de Jong, PhD
4:00 PM – Treating Multiple Tumors in a Single Plan on the X1
Mason Hazlett, MS
SCINTIX THERAPY
SCINTIX® technology is a novel therapy for patients with tumors in the lung or bone arising from primary and metastatic cancer. This breakthrough technology uses live, continuously updated data throughout the entire treatment session to determine where to deliver radiotherapy.
DISCLOSURES
As a health care professional attendee of this event, you understand and agree that for purposes of complying with RefleXion’s mandatory transparency reporting obligations under the Patient Protection and Affordable Care Act (together with any regulations and official guidelines promulgated thereunder) and any applicable state reporting requirements, RefleXion may collect, aggregate and report any and all payments made pursuant to this event.